Do I need to take Su Kexin/Avatrombopag tablets all the time?
AvatrombopagWhether you need to take Avatrombopag tablets all the time cannot be generalized. It mainly depends on the patient's illness, physical condition and response to the drug.
Avatrombopag is an oral, small molecule thrombopoietin receptor agonist, mainly used to treat thrombocytopenia related to chronic liver disease (CLD), as well as thrombocytopenia and immune thrombocytopenia caused by chemotherapy. It promotes platelet production by stimulating the proliferation and differentiation of megakaryocytes in bone marrow progenitor cells to increase the patient's platelet count and reduce the risk of bleeding.

For most patients, treatment cycles with avatrombopag are usually limited and do not need to be taken continuously. Generally speaking, patients will take a certain course of medication under the guidance of a doctor according to their condition, such as a box (usually 15 tablets) once a day for two weeks. During treatment, doctors will regularly monitor the patient's platelet count to evaluate the drug's effectiveness. If the patient's platelet count reaches a safe level and the patient's condition is stable, the doctor may consider discontinuing the drug or reducing the dose. However, in some patients with severe or complex conditions, such as those with extremely low platelet counts or those at risk for ongoing bleeding, long-term treatment with avatrombopag may be necessary to maintain platelet counts within a safe range.
However, despite the significant therapeutic benefits of avatrombopag, caution is required during use. Studies have shown that TPO receptor agonists are associated with thrombosis and thromboembolic complications in patients with chronic liver disease. Therefore, physicians need to closely monitor patients for symptoms related to thromboembolism during the use of avatrombopag. At the same time, doctors should also pay enough attention to possible side effects, such as headache, nausea, and fatigue, to ensure the safety and effectiveness of the entire treatment process.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)